Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | |
|---|---|---|---|---|
| Total revenue | 21.64K | |||
| Operating revenue | --21.64K | ---- | ---- | ---- |
| Cost of revenue | ||||
| Gross profit | 21.64K | |||
| Operating expense | 6.23%9.98M | 18.99%9.4M | 92.45%7.9M | 4.1M |
| Selling and administrative expenses | 24.32%5.39M | 70.22%4.33M | 27.24%2.54M | --2M |
| -Selling and marketing expense | 13.11%269.51K | 22.30%238.26K | 49.45%194.82K | --130.36K |
| -General and administrative expense | 24.97%5.12M | 74.19%4.09M | 25.70%2.35M | --1.87M |
| Research and development costs | -16.77%1.57M | -41.64%1.89M | 187.68%3.23M | --1.12M |
| Depreciation amortization depletion | 72.82%1M | 410.31%579.79K | 451.34%113.62K | --20.61K |
| -Depreciation and amortization | 72.82%1M | 410.31%579.79K | 451.34%113.62K | --20.61K |
| Other operating expenses | -22.06%2.03M | 29.59%2.6M | 109.07%2.01M | --959.17K |
| Operating profit | -6.00%-9.96M | -18.99%-9.4M | -92.45%-7.9M | -4.1M |
| Net non-operating interest income (expenses) | 290.78%92.59K | -205.25%-48.54K | 147.43%46.11K | 18.64K |
| Non-operating interest income | 259.24%184.62K | -17.31%51.39K | 233.49%62.15K | --18.64K |
| Non-operating interest expense | 8.26%45.72K | --42.23K | ---- | ---- |
| Total other finance cost | -19.74%46.31K | 259.71%57.69K | --16.04K | ---- |
| Other net income (expenses) | -13.72%2.63M | 9.18%3.05M | 298.63%2.79M | 700.03K |
| Other non-operating income (expenses) | -13.72%2.63M | 9.18%3.05M | 298.63%2.79M | --700.03K |
| Income before tax | -13.14%-7.24M | -26.44%-6.4M | -49.51%-5.06M | -3.39M |
| Income tax | 0 | 0 | 0 | 0 |
| Earnings from equity interest net of tax | ||||
| Net income | -13.14%-7.24M | -26.44%-6.4M | -49.51%-5.06M | -3.39M |
| Net income continuous operations | -13.14%-7.24M | -26.44%-6.4M | -49.51%-5.06M | ---3.39M |
| Noncontrolling interests | ||||
| Net income attributable to the company | -13.14%-7.24M | -26.44%-6.4M | -49.51%-5.06M | -3.39M |
| Preferred stock dividends | ||||
| Other under preferred stock dividend | ||||
| Net income attributable to common stockholders | -13.14%-7.24M | -26.44%-6.4M | -49.51%-5.06M | -3.39M |
| Diluted earnings per share | 22.69%-0.0201 | -8.33%-0.026 | -44.58%-0.024 | -0.0166 |
| Basic earnings per share | 22.69%-0.0201 | -8.33%-0.026 | -44.58%-0.024 | -0.0166 |
| Dividend per share | ||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP |